Advertisement

cancer talk

  • Drug Delays Recurrence in People With Early-Stage Breast Cancer

    People who have inherited BRCA mutations and are at high risk for cancer recurrence may benefit from a PARP inhibitor.

    by Pamela Rafalow Grossman

  • Open Medical Records: Pros and Cons

    Patients now have full access to their online medical records. What are the benefits and downsides?

    by Jen Tota McGivney

  • Remote Care

    After adapting remote patient monitoring programs to cancer patients with COVID-19, cancer centers delve deeper into the programs’ value for cancer patients undergoing treatment.

    by Jon Kelvey

  • Moving Away From the Maximum Tolerated Dose

    The FDA recently expressed a new commitment to testing cancer drugs at lower doses, rather than defaulting to the highest dose most people can tolerate.

    by Marcus A. Banks

  • The Individual Sphere of Influence

    Can discussion of health inequities lead to actionable change?

    by Marci A. Landsmann

  • A Treatment That Came Just in Time

    Cancer survivor Laurie Adami reflects on her experience participating in a clinical trial that ultimately contributed to the March 2021 approval of a CAR-T cell therapy for follicular lymphoma.

    by Laurie Adami

  • More Data on COVID-19 Vaccination and Cancer

    Studies indicate that many people with cancer have an antibody response to the vaccines, but this response may be reduced or absent in certain patients.

    by Anna Goshua

  • Putting the Patient in the Driver’s Seat

    In her new book, Cancer Support Community executive chair Kim Thiboldeaux offers advice to patients on how to steer their way through a cancer diagnosis, treatment and beyond.

    by Kevin McLaughlin

  • A Closer Look at Sarcopenia

    Gastrointestinal oncologist and health services researcher Ryan Nipp discusses new research about how muscle quality correlates with cancer outcomes.

    by Ashley P. Taylor

  • Genetic Testing Gaps

    Testing for hereditary mutations is increasingly recommended for people with cancer, but recommendations do not always translate into access to testing and appropriate counseling.

    by Kate Yandell

Advertisement

Advertisement

From the AACR

Advertisement

Video

Learning Medicare’s ABCDs

Advertisement

social media

donate to the AACR